Dynamic contrast‐enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP‐9) expression in brain tuberculomas
Open Access
- 5 September 2008
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 28 (3) , 588-597
Abstract
Purpose: To correlate dynamic contrast‐enhanced (DCE) MRI derived perfusion indices with immunohistochemically obtained vascular endothelial growth factor (VEGF) and matrix metalloproteinase‐9 (MMP‐9) in a cellular fraction of brain tuberculomas (BT).Materials and Methods: Thirteen BT patients underwent DCE MRI. Perfusion indices (cerebral blood volume [CBV], transfer coefficient [ktrans] and leakage [ve]) maps were generated for the quantitative analysis. The CBV was corrected for the leaky blood–brain barrier (BBB). The relative CBV (rCBV), ktrans, and ve were calculated by placing 10 regions of interest (ROIs) showing the highest values in the lesion. The percentage area of VEGF and percentage area of MMP‐9 and microvessel density (MVD) were quantified from 10 fields per lesion with maximal expression of the excised BT. Pearson correlation analysis between physiological indices and quantitative VEGF, MMP‐9, and MVD was performed for each ROI.Results: The average value of rCBV, ktrans, ve, VEGF, MMP‐9, and MVD were 3.53 ± 0.37, 2.04 ± 0.40 min−1, 0.71 ± 0.09, 12.51 ± 2.56, 18.09 ± 2.06, 10.87 ± 1.99, respectively. The ktrans (r = 0.918, P < 0.001) and ve (r = 0.899, P < 0.001) showed significant correlation with MMP‐9, while rCBV correlated significantly with MVD (r = 0.962, P < 0.001) and VEGF (r = 0.868, P < 0.001).Conclusion: We conclude that the expression of MMP‐9, a marker of BBB disruption and disease activity in BT correlates with DCE‐derived ktrans and thus has the potential to be used as its surrogate marker. J. Magn. Reson. Imaging 2008;28:588–597.Keywords
This publication has 49 references indexed in Scilit:
- Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-α in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2007
- MMPs contribute to TNF-α-induced alteration of the blood-cerebrospinal fluid barrier in vitroAmerican Journal of Physiology-Cell Physiology, 2007
- DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsBritish Journal of Cancer, 2007
- IFN' synergizes with IL‐1α to up‐regulate MMP‐9 secretion in a cellular model of central nervous system tuberculosisThe FASEB Journal, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Infectious AngiogenesisThe American Journal of Pathology, 2003
- Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI dataBritish Journal of Radiology, 2003
- High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysisMagnetic Resonance in Medicine, 1996
- MR Imaging of Intracranial TuberculomasJournal of Computer Assisted Tomography, 1988
- Intracranial tuberculomas: a CT studyBritish Journal of Radiology, 1980